$ Value
$0
Shares
40,000
Price
$0
Filed
Mar 27
Insider
Name
Collins Helen Louise
Title
CHIEF MEDICAL OFFICER
CIK
0001701247
Roles
Transaction Details
Transaction Date
2026-03-25
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
136,268
Footnotes
The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2025. | Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | This transaction was executed in multiple trades at prices ranging from $35.00 to $35.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Filing Info
Collins Helen Louise's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | ELVN | M | $12K |
| 2026-04-17 | ELVN | ▼ | $6K |
| 2026-04-17 | ELVN | ▼ | $115K |
| 2026-04-17 | ELVN | ▼ | $117K |
| 2026-04-17 | ELVN | M | $0 |
| 2026-03-25 | ELVN | M | $99K |
| 2026-03-25 | ELVN | ▼ | $1.4M |
| 2026-03-25 | ELVN | M | $0 |
| 2026-03-10 | ELVN | M | $25K |
| 2026-03-10 | ELVN | ▼ | $306K |
Other Insiders at ELVN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Garland J. Scott | — | — | 2026-02-12 |
| Kunkel Lori Anne | — | — | 2026-02-12 |
| Gupta Rishi | — | — | 2026-02-12 |
| Heyman Richard A. | — | $32K | 2026-02-17 |
| Bauer Jake | — | — | 2026-02-12 |
|
Collins Helen Louise
CHIEF MEDICAL OFFICER
|
— | $4.0M | 2026-04-17 |
| Ballal Rahul D. | — | — | 2026-02-12 |
| Derynck Mika K | — | — | 2026-02-12 |
|
Hohl Benjamin
CHIEF FINANCIAL OFFICER
|
— | $296K | 2026-03-06 |
|
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
|
— | $145K | 2026-02-12 |
|
Patel Anish
CHIEF OPERATING OFFICER
|
— | — | 2026-02-12 |